Biomarin news | Breaking News & Top Stories

In the last month

Top biotech deals in May 2025 Labiotech14:10 2-Jun-25

Is the Options Market Predicting a Spike in BioMarin Pharmaceutical Stock? Zacks17:44 28-May-25

BioMarin Offers to Buy Inozyme for $270M to Boost Enzyme Therapy Biz Zacks15:14 19-May-25

BioMarin agrees to acquire Inozyme for $270m Pharmaceutical Technology09:18 19-May-25

BioMarin starts rebuilding after its downsizing spree pharmaphorum08:52 19-May-25

StockWatch: With Inozyme Buyout, BioMarin Pursues Growth via M&A Genetic Engineering and Biotechnology News00:20 19-May-25

BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma PR Newswire (Press Release)12:37 16-May-25

view more headlines

2 Jun 14:10

Biotech Top Stories

Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA… Business Wire (Press Release)11:04
STAT Plus: Recursion CEO: Biotech’s rainy season is not over — but we must race ahead STAT09:37
Alex Telford on AI, drug discovery, digital twins, and the most interesting questions in biotech Labiotech09:04
Data at EULAR back Biogen, UCB's first-in-class lupus drug pharmaphorum08:40
FDA approves label expansion of AbbVie hepatitis C therapy Pharmaceutical Technology08:31